Akso Health Group (AHG) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Akso Health Group stock $0.76, price $1.33, that is 42.9% below the price, quality 24 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Akso Health Group
AHG · USFar too expensive (fair value 43% below the price), weak company and price moving sideways: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range $0.2510 – $18.87 · fair‑value band $0.5700 – $0.9400 · the $1.33 price screens above the $0.7600 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 16, 2026.
Every Wednesday you see whether Akso Health is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China.
Show moreShow less
It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations.
The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export.
The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Stock analysis
Akso Health Group (AHG) currently trades at $1.33, while our estimate is $0.7600, 43% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $0.5700 (bear) to $0.9400 (bull), the price of $1.33 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 24/100 (below-average quality), in the Healthcare sector.
Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Akso Health Group reported revenue of $13.8M in FY2026 versus $6.3M in FY2022, a compound +21.7%/yr. Reported net income was −$18.7M in FY2026.
Key figures
Market cap $1.1B Small · P/S ratio 80.5 · EPS (TTM) $−0.0300 · Net margin −135% · Return on equity −9.9% · Return on assets (EBIT) −37.0% (5-year average) · Operating margin −37.5% · Revenue (TTM) $13.8M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).
What moves the price
The share trades about 47% below its 52-week high and 92% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 36% fair-value upside, at −43%, AHG screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
AHG screens overvalued: fair value 43% below the price. Compare with McKesson Corporation →
Compare Akso Health Group with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 82 stocks
Valuation Multiplesvs Medical Distribution median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Sinopharm Group 1099 | HK$16.96 | HK$50.88 | +200% | vs AHG |
| Jointown Pharmaceutical Group 600998 | ¥5.25 | ¥11.56 | +120% | vs AHG |
| Shanghai Pharmaceuticals Holding 601607 | ¥16.51 | ¥35.78 | +117% | vs AHG |
| China National Medicines Corporation 600511 | ¥28.87 | ¥58.47 | +103% | vs AHG |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥19.59 | ¥26.64 | +36% | vs AHG |
| Cencora, Inc COR | $356.94 | $341.58 | −4% | vs AHG |
| Henry Schein, Inc HSIC | $84.96 | $78.69 | −7% | vs AHG |
| McKesson Corporation MCK | $1,105 | $822.74 | −26% | vs AHG |
| Galenica AG GALE | CHF 91.40 | CHF 61.79 | −32% | vs AHG |
| Cardinal Health, Inc CAH | $283.85 | $163.14 | −43% | vs AHG |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Akso Health Group (AHG) overvalued or undervalued?
What is the fair value of AHG?
What is the quality score of AHG?
What is the price target for Akso Health Group (AHG)?
What is the Akso Health Group stock forecast for 2026?
What is the revenue of Akso Health Group (AHG)?
What is the intrinsic value of Akso Health Group (AHG)?
Is Akso Health Group stock overvalued or undervalued in 2026?
Is fair value the same as the market price of AHG?
How much is Akso Health Group worth?
What do the bullish and bearish scenarios say about AHG?
How solid is the balance sheet of Akso Health Group (AHG)?
How far is AHG from its 52-week high?
Which stocks are comparable to Akso Health Group?
Is Akso Health Group stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Akso Health Group (AHG)?
What should I pay attention to with Akso Health Group right now?
Key figures of Akso Health Group
How large is the market capitalisation of Akso Health Group (AHG)?
What is the P/S ratio of Akso Health Group (AHG)?
What are the earnings per share of Akso Health Group (AHG)?
What is the net margin of Akso Health Group (AHG)?
What is the return on equity of Akso Health Group (AHG)?
What is the EBIT return on assets of Akso Health Group (AHG)?
What is the operating margin of Akso Health Group (AHG)?
How fast is revenue growing at Akso Health Group (AHG)?
How much free cash flow does Akso Health Group (AHG) generate?
How much net debt does Akso Health Group (AHG) carry?
Watch Akso Health Group in the live analysis
One click puts Akso Health Group on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.